community-acquired pneumonia (CAP) Macrolide-resistant Mycoplasma pneumoniae, Community-acquired pneumonia, Mycoplasma
Conditions
Interventions
Children and adolescents aged 1 month to 18 years who were diagnosed with CAP and received care at Siriraj Hospital.
Diagnostic
Pediatric CAP patients
Sponsors
Siriraj Research and Development Fund
Eligibility
Sex/Gender
All
Age
1 Months to 18 Years
Inclusion criteria
Inclusion criteria: 1. children and adolescents, 2. diagnosed with CAP , 3. receiving care at Siriraj Hospital, including both outpatients and inpatients, 4. Patients or their legal guardians voluntarily agree to participate in the study by signing the informed consent form
Exclusion criteria
Exclusion criteria: 1. identification of respiratory pathogens other than M. pneumoniae in nasopharyngeal samples, 2. onset of respiratory symptoms more than 72 hours after hospital admission.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MRMP infection status At diagnosis Real-time Polymerase Chain Reaction and macrolide resistance gene sequencing | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment responses 72 hours after treatment, Time to defervescence, End of treatment Clinical symptom resolution,Factors associated with MRMP infection At the beginning of study History of Macrolide and antibiotic use within 3 months, Hospitalization in the past 3 months, Demographic data (age, sex, underlying condition, no. of household members), daycare attendance | — |
Countries
Thailand
Contacts
Public ContactWanatpreeya Phongsamart
Siriraj Hospital Mahidol University
Outcome results
None listed